Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 50 citations · 35 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsLead Compound DesignLigand-based DesignMonoamine NeurochemistryPotency OptimizationQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisChemical Structure-activity RelationshipsChemical SubstituentsMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsNitro CompoundsPhenyl Ring Substitution EffectsStructure-activity Relationship ModelingSubstituent Effects On Biological Activity
A new series of 4-(3-nitrophenyl)thiazol-2-ylhydrazone derivatives were designed, synthesised, and evaluated to assess their inhibitory effect on the human monoamine oxidase (hMAO) A and B isoforms. Different (un)substituted (hetero)aromatic substituents were linked to N1 of the hydrazone in order to establish robust structure-activity relationships. The results of the biological testing demonstrated that the presence of the hydrazothiazole nucleus bearing at C4 a phenyl ring functionalised at the meta position with a nitro group represents an important pharmacophoric feature to obtain selective and reversible human MAO-B inhibition for the treatment of neurodegenerative disorders. In addition, the most potent and selective MAO-B inhibitors were evaluated in silico as potential cholinesterase (AChE/BuChE) inhibitors and in vitro for antioxidant activities. The results obtained from molecular modelling studies provided insight into the multiple interactions and structural requirements for the reported MAO inhibitory properties.
35